ESC 365 - Pulmonary hypertension is an adverse risk factor for patients admitted with atrial fibrillation

ESC Professional Premium Access

Pulmonary hypertension is an adverse risk factor for patients admitted with atrial fibrillation

Session: Predictors for atrial fibrillation

Topic: Clinical

Speaker: Doctor M. Kodali (Milwaukee, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mouna Kodali

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)

0 follower

7 more presentations in this session

Epicardial fat can predict the in-atrial thrombus in patients with atrial fibrillation

Speaker: Doctor M. Tang (CN)

A cardiac rehabilitation and those effects using cardiopulmonary exercise testing in patients undergoing catheter ablation for atrial fibrillation

Speaker: Doctor S. Maeda (Kawasaki, JP)

The association of vasoactive agents with postoperative atrial fibrillation after cardiac surgery

Speaker: Doctor A. Hammer (Vienna, AT)

Patterns of comorbidities and influence on the natural history of patients with atrial fibrillation: a latent class analysis from a prospective observational european AF registry

Speaker: Doctor G. Romiti (Rome, IT)

Role of liver disease in management and outcomes of european and asian patients with atrial fibrillation: a report from two regional prospective observational AF registries

Speaker: Doctor D. Mei (Modena, IT)

Access the full session

Predictors for atrial fibrillation

Speakers: Doctor M. Kodali, Doctor M. Tang, Doctor S. Maeda, Doctor A. Hammer, Doctor G. Romiti...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources